The Investigation of Percutaneous Tibial Nerve Stimulation (PTNS) as a Minimally Invasive, Non-Surgical, Non-Hormonal Treatment for Overactive Bladder Symptoms

Author:

McPhail Connor1,Carey Robert2,Nambiar Sidharth3,Willison Nadia1,Bahadori Saghi4,Aryan Pouria15ORCID,Nguyen Tran14ORCID,Behnia-Willison Fariba123

Affiliation:

1. FBW Gynaecology Plus, Adelaide 5035, Australia

2. Department of Obstetrics & Gynaecology, Flinders Medical Centre, Bedford Park 5042, Australia

3. Flinders University, Adelaide 5042, Australia

4. Adelaide Medical School, University of Adelaide, Adelaide 5005, Australia

5. School of Electrical & Electronic Engineering, University of Adelaide, Adelaide 5005, Australia

Abstract

Background: Overactive bladder (OAB) syndrome affects 10–15% of women, severely impacting their quality of life. First-line treatments include behavioural and physical therapy, and second-line medical treatments include medications such as vaginal oestrogen, anticholinergic medications, and ß3-adrenergic agonists—with potential adverse side effects including dizziness, constipation, and delirium, particularly affecting elderly populations. Third-line treatments include more invasive measures, including intradetrusor botulinum injections or sacral nerve modulation, with percutaneous tibial nerve stimulation (PTNS) being a potential alternative treatment. Aims: The aim of this study was to explore the long-term efficacy of PTNS treatment for OAB in an Australian cohort. Materials and Methods: This is a prospective cohort study. Patients underwent Phase 1 treatment, whereby women received PTNS treatment once per week for 12 weeks. Following Phase 1, women entered Phase 2, whereby they received 12 PTNS treatments over 6 months. Their response to treatment was measured by obtaining data before and after each phase using ICIQ-OAB and the Australian Pelvic Floor Questionnaire (APFQ). Results: Phase 1 included 166 women, with 51 completing Phase 2. There was a statistically significant reduction in urinary urgency (29.8%), nocturia (29.8%), incontinence (31.0%), and frequency (33.8%) compared to the baseline. Patients who completed Phase 2 also showed a statistically significant reduction in urinary frequency (56.5%). Conclusions: Overall, the results from this study are positive and support that PTNS is a minimally invasive, non-surgical, non-hormonal, and effective treatment for OAB. These results suggest that PTNS may be a second-line treatment for patients with OAB not responding to conservative management or for patients aiming to avoid surgical approaches.

Publisher

MDPI AG

Subject

General Medicine

Reference28 articles.

1. Definition and epidemiology of overactive bladder;Wein;Urology,2002

2. Overactive bladder and women’s sexual health: What is the impact?;Coyne;J. Sex. Med.,2007

3. Overactive bladder significantly affects quality of life;Abrams;Am. J. Manag. Care,2000

4. The economic impact of overactive bladder syndrome in six Western countries;Irwin;BJU Int.,2009

5. Pelvic organ prolapse surgery and overactive bladder symptoms–a population-based cohort (FINPOP);Karjalainen;Int. Urtogynecol. J.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3